Dr. Hossein Jadvar is a tenured Associate Professor of Radiology, Urology, and Biomedical Engineering at the University of Southern California (USC), in Los Angeles, California, USA. He received his PhD in bioengineering from University of Michigan (Ann Arbor), the MD degree from University of Chicago (Pritzker), master’s in public health (MPH) from Harvard University, and master’s in business administration (MBA) from USC. His completed an internship in internal medicine at University of California, San Francisco (UCSF), residency in diagnostic radiology and nuclear medicine at Stanford University, and fellowship in PET at Harvard Medical School. Dr. Jadvar is past president and fellow of both the American College of Nuclear Medicine (ACNM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI).  He has been an NIH funded investigator and serves on multiple NIH review panels, Department of Defense and the Cancer Prevention Research Institute of Texas. He is on the leadership editorial boards of the Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging (Associate Editor), Radiology (Consultant to the Editor), and Clinical Nuclear Medicine (Deputy Editor), and is member of the editorial boards of many other peer-reviewed scientific journals. He is the past recipient of the SNMMI Mark Tetalman Young Investigator Award, the Western Regional SNMMI Distinguished Scientist Award, the Academy of Radiology and Biomedical Imaging Research Distinguished Investigator Award, the inaugural fellowship in the USC Center for Excellence in Research, the inaugural Prof. Ajit Padhy Award from the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), the SNMMI PET Center of Excellence Peter E. Valk MD Memorial Award, and the Best Mentor Awards from both USC and the ACNM.  Dr. Jadvar serves on the Advisory Committee on Medical Uses of Isotopes (ACMUI) of the United States Nuclear Regulatory Commission (U.S. NRC).  He has written more than 150 peer-reviewed journal articles, published 4 books, 38 book chapters, 9 U.S. and European patents, numerous conference abstracts and full articles, and has had more than 200 invited speaker presentations and visiting professorships at national and international venues. He is involved in translational molecular imaging research with particular current interest in prostate cancer, theranostics, and radiopharmaceutical therapy.